Pallas Capital Advisors LLC Buys 6,384 Shares of Molina Healthcare, Inc $MOH

Pallas Capital Advisors LLC lifted its stake in shares of Molina Healthcare, Inc (NYSE:MOH) by 105.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 12,431 shares of the company’s stock after acquiring an additional 6,384 shares during the period. Pallas Capital Advisors LLC’s holdings in Molina Healthcare were worth $2,379,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Concurrent Investment Advisors LLC increased its stake in Molina Healthcare by 7.0% in the second quarter. Concurrent Investment Advisors LLC now owns 944 shares of the company’s stock valued at $281,000 after acquiring an additional 62 shares during the last quarter. Asset Management One Co. Ltd. lifted its stake in Molina Healthcare by 0.3% during the third quarter. Asset Management One Co. Ltd. now owns 22,737 shares of the company’s stock worth $4,351,000 after purchasing an additional 66 shares during the last quarter. Twin Capital Management Inc. boosted its holdings in shares of Molina Healthcare by 6.3% in the 2nd quarter. Twin Capital Management Inc. now owns 1,181 shares of the company’s stock worth $352,000 after purchasing an additional 70 shares in the last quarter. Parkside Financial Bank & Trust increased its position in shares of Molina Healthcare by 18.9% during the 2nd quarter. Parkside Financial Bank & Trust now owns 446 shares of the company’s stock valued at $133,000 after purchasing an additional 71 shares during the last quarter. Finally, Applied Finance Capital Management LLC grew its position in Molina Healthcare by 5.7% during the third quarter. Applied Finance Capital Management LLC now owns 1,408 shares of the company’s stock valued at $269,000 after acquiring an additional 76 shares during the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Molina Healthcare

In related news, Director Richard M. Schapiro sold 357 shares of the business’s stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $143.02, for a total value of $51,058.14. Following the completion of the transaction, the director directly owned 11,352 shares in the company, valued at $1,623,563.04. The trade was a 3.05% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.26% of the stock is currently owned by insiders.

Molina Healthcare Trading Up 6.7%

Shares of NYSE MOH opened at $135.20 on Tuesday. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.69 and a quick ratio of 1.69. The firm has a 50-day moving average of $170.68 and a 200 day moving average of $169.32. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $359.97. The stock has a market cap of $6.96 billion, a P/E ratio of 15.79 and a beta of 0.49.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Thursday, February 5th. The company reported ($2.75) earnings per share for the quarter, missing the consensus estimate of $0.43 by ($3.18). Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.The company had revenue of $11.38 billion during the quarter, compared to analysts’ expectations of $10.90 billion. During the same quarter in the previous year, the company earned $5.05 EPS. The business’s quarterly revenue was up 8.3% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, sell-side analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. UBS Group restated a “neutral” rating and issued a $145.00 price objective on shares of Molina Healthcare in a report on Monday, February 9th. Cantor Fitzgerald decreased their price objective on Molina Healthcare from $180.00 to $144.00 and set a “neutral” rating on the stock in a report on Monday, February 9th. The Goldman Sachs Group dropped their price target on shares of Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research report on Wednesday, February 11th. Truist Financial set a $175.00 price target on Molina Healthcare in a report on Friday, October 24th. Finally, Deutsche Bank Aktiengesellschaft set a $109.00 price target on Molina Healthcare in a research report on Tuesday, February 10th. Three investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $164.79.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.